Pages

▼
Friday, June 12, 2026

Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated Care (rerun)

›
This week, we’re rerunning some popular posts while we prepare for today’s live video webinar: 340B in 2026: Market Shifts, Policy Battles, ...
Thursday, June 11, 2026

The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground (rerun)

›
This week, we’re rerunning some popular posts while we prepare for tomorrow’s live video webinar: 340B in 2026: Market Shifts, Policy Battle...
Wednesday, June 10, 2026

Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update (rerun)

›
This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles,...
Tuesday, June 09, 2026

The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments (rerun)

›
This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles,...
Monday, June 08, 2026

The Top 15 U.S. Pharmacies of 2025: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)

›
This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles,...
Friday, June 05, 2026

Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight

›
Today’s guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx’s proprietary data an...
Tuesday, June 02, 2026

The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs

›
By Adam J. Fein, Ph.D. and Greis Kapexhiu It’s time for Drug Channels Institute’s latest exclusive analysis of the 340B contract pharmacy m...
Friday, May 29, 2026

Drugs, Discounts and Data: Crafting Sustainability in an Imperfect System

›
Today’s guest post comes from Angie Franks, Chief Executive Officer at Kalderos. As Angie explains, the industry still lacks the transparen...
Wednesday, May 27, 2026

Drug Channels News Roundup, May 2026: My $0.02 on Optum Rx’s Transparency, Must-Read 340B History, PBM Unbundling Update, PA Delays, and Vegas Fun

›
By Adam J. Fein, Ph.D. Summer unofficially kicked off last weekend. So fire up the grill and enjoy these noteworthy delicacies, seared to pe...
Wednesday, May 20, 2026

PBM Shakeout: How Vertical Integration Is Reshaping What’s Next (VIDEO)

›
Here at Drug Channels , we’ve been closely tracking the evolution of the pharmacy benefit management (PBM) industry for many years. The sho...
Friday, May 15, 2026

Protecting Gross-to-Net Performance Through Single-Channel Ecosystems

›
Today’s guest post comes from Peter Darch, SVP of Strategy and Operations at PHIL Inc. Peter explains that growing pressure on drug prici...
Wednesday, May 13, 2026

Drug Channels News Roundup, Mid-May 2026: Flawed Launch Price Math, Rising Pharmacy Closures, Hospital Pay Realities, 340B Hospitals vs. Grantees, and a Luxury Take on Specialty Pharmacy

›
By Bryce Platt, PharmD The onslaught of pharmacy-related news doesn’t end. It may even be increasing in volume due to AI. But don’t worr...